Trial design drives outcomes: harmonising efficacy across <scp>BCG</scp> ‐unresponsive bladder carcinoma <i>in situ</i> trials

Daniele Robesti, Ashish M. Kamat, Guillaume Ploussard, Roberto Contieri, Giuseppe Fallara, Alberto Briganti, Francesco Montorsi, Antoine G. van der Heijden, Bernard Malavaud, Kamal Pohar, Neal Shore, Colin P. N. Dinney, Alberto Martini

Open source

DOI: 10.1111/bju.70463
Published: 2026-09-25
Container: BJU International
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bju.70463,
  title = {Trial design drives outcomes: harmonising efficacy across
                    <scp>BCG</scp>
                    ‐unresponsive bladder carcinoma
                    <i>in situ</i>
                    trials},
  author = {Daniele Robesti and Ashish M. Kamat and Guillaume Ploussard and Roberto Contieri and Giuseppe Fallara and Alberto Briganti and Francesco Montorsi and Antoine G. van der Heijden and Bernard Malavaud and Kamal Pohar and Neal Shore and Colin P. N. Dinney and Alberto Martini},
  year = {2026},
  journal = {BJU International},
  doi = {10.1111/bju.70463},
  url = {https://doi.org/10.1111/bju.70463}
}

RIS

TY  - JOUR
TI  - Trial design drives outcomes: harmonising efficacy across
                    <scp>BCG</scp>
                    ‐unresponsive bladder carcinoma
                    <i>in situ</i>
                    trials
AU  - Daniele Robesti
AU  - Ashish M. Kamat
AU  - Guillaume Ploussard
AU  - Roberto Contieri
AU  - Giuseppe Fallara
AU  - Alberto Briganti
AU  - Francesco Montorsi
AU  - Antoine G. van der Heijden
AU  - Bernard Malavaud
AU  - Kamal Pohar
AU  - Neal Shore
AU  - Colin P. N. Dinney
AU  - Alberto Martini
PY  - 2026
JO  - BJU International
DO  - 10.1111/bju.70463
UR  - https://doi.org/10.1111/bju.70463
ER  -

APA

Robesti, D., Kamat, A. M., Ploussard, G., Contieri, R., Fallara, G., Briganti, A., Montorsi, F., Heijden, A. G. V. D., Malavaud, B., Pohar, K., Shore, N., Dinney, C. P. N., & Martini, A. (2026). Trial design drives outcomes: harmonising efficacy across <scp>BCG</scp> ‐unresponsive bladder carcinoma <i>in situ</i> trials. BJU International. https://doi.org/10.1111/bju.70463

Source records

crossref · retrieved 2026-09-26T16:04:48.733Z